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N itrate is a relatively inert molecule generated in humansthrough the oxidation of endogenously synthesized
nitric oxide (NO). We are also exposed to inorganic nitrate
through dietary ingestion, with dietary exposure typically
equaling or exceeding that of endogenous synthesis. There
has been concern following work conducted in the 1970s that
nitrate from the diet may be a precursor to the synthesis of
carcinogenic N-nitrosamines in the human gastrointestinal
tract.1 This seemed to be supported by a number of
epidemiological studies showing a correlation between nitrate
exposure and a range of malignancies. The study by Maas
et al in this issue of JAHA adds to this debate.
Since the discovery in 1994, by 2 independent groups, that
inorganic nitrate may act as a source of nitric oxide (NO) in
humans,2,3 subsequent research has challenged the view that
nitrate is harmful. It is clear that nitrate, whether from the diet
or from the oxidation of endogenously synthesized NO, is
involved in a complex enterosalivary circulation. Brieﬂy,
nitrate is concentrated in the salivary glands such that
salivary nitrate concentrations are 109 that of plasma.
Nitrate in saliva is reduced to nitrite by anaerobic bacteria on
the tongue and swallowed. Some of this nitrite is converted to
NO in the stomach, which appears to be important for
regulation of gastric function and protection against enteric
pathogens. Some nitrite is then absorbed into the circulation,
such that plasma nitrite concentrations rise dramatically after
a nitrate-rich meal (for example, green leafy vegetables or
beetroot). Under conditions of hypoxia or acidosis, nitrite is
further reduced to NO. This appears to provide an alternative
source of NO when endogenous synthesis through the
oxygen-dependent L-arginine NO synthase pathway is
impaired. Trials of supplementation have suggested that
adding nitrate to the diet can lower blood pressure, reduce
the oxygen cost of exercise, and protect against ischemia–
reperfusion injury,4 although not all studies report such
changes.5
The potential beneﬁts of nitrate from the diet have led to
calls from some quarters to raise the recommended daily
intake. There do, however, remain a number of signiﬁcant
unanswered questions in the ﬁeld.
Dietary nitrate supplementation studies have typically had
small sample sizes and been of short duration.
There have been multiple large population studies sug-
gesting harm related to nitrate ingestion.6 Nitrate exposure is
very difﬁcult to estimate accurately, even beyond the well-
known limitations of food diaries and food recall–based
studies. Most of our exposure to nitrate comes from
vegetables. The nitrate content of a given vegetable will vary
according to where it grown, how much fertilizer is used, and
even the time of day it is harvested.
Numerous studies have used red meat or processed meat
as a proxy for nitrate intake. In 1 recent study, the National
Institutes of Health–American Association of Retired Persons
Diet and Health study, those in the highest category of meat-
derived nitrate consumption were ingesting on average
approximately 0.035 mmol/d from meat sources. Given that
in the typical Western diet 1 to 2 mmol of nitrate is
consumed, it seems unlikely that nitrate itself is a cause of
the increased mortality associated with a meat-rich diet.
When considering nitrate exposure from vegetables, evidence
for a protective effect emerges.7
There are few population data with measured nitrate
exposure to inform the debate one way or the other. Our
group has recently shown an inverse association between
higher 24-hour nitrate excretion and blood pressure in a
model that included adjustment for antihypertensive medica-
tion; in this model, lower blood pressure would reasonably be
expected to be associated with lower rates of cardiovascular
disease.8
In this issue of JAHA, the examination by Maas et al of
plasma nitrate and incidence of cardiovascular disease and
all-cause mortality from the Framingham Offspring Study is
the largest data set using a robust measure of plasma nitrate
performed to date, with a median follow-up of 17.3 years.9
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In a model adjusted for age, sex, body mass index, systolic
blood pressure, antihypertensive medication, smoking, dia-
betes mellitus, the total high-density lipoprotein cholesterol
ratio, heart rate, and high alcohol consumption and C-reactive
protein, they found a hazard ratio of 1.21 (1.04–1.40) for all-
cause mortality for each 1-unit increase in ln-nitrate
(P=0.015). When further adjusted for estimated glomerular
ﬁltration rate, this association was weakened (1.16 [1.00–
1.35], P=0.057). There was no association with incident
cardiovascular disease.
It is notable that in conditions known to have a causal
relationship with mortality (impaired kidney function, smok-
ing, hypertension, and diabetes mellitus), plasma nitrate was
higher in this cohort. This is somewhat surprising in that, in at
least some of these settings, NO synthesis has been
demonstrated to be lower than in controls.10,11 Why then, is
plasma nitrate higher in these groups?
It has previously been suggested that circulating nitrite
reﬂects endothelial NO synthesis, whereas nitrate concentra-
tions do not.12 The short duration of such experiments, the
relative abundance of nitrate compared with nitrite in plasma,
and difference in stability of these 2 products mean that this
conclusion cannot be supported by data in the literature. In
experiments of longer duration in animals, it is clear that in
the absence of exogenous sources of nitrate, there is a
substantial contribution to circulating nitrate concentrations
from endothelial NO synthesis.13 Based on these ﬁndings,
plasma nitrate concentration can provide insights into vascu-
lar health in low dietary nitrate conditions.
The data from Kelm’s group raise the possibility of a
paradoxical relationship between plasma nitrate and nitrite
concentrations and vascular health.14 In healthy subjects,
plasma nitrate concentration was 281 lmol/L and plasma
nitrite concentration was 35113 nmol/L. For those with 4 or
more cardiovascular risk factors, the plasma nitrate concen-
tration was 354 lmol/L and plasma nitrite concentration
was 17129 nmol/L (both P<0.001). This higher plasma
nitrate concentration with increasing numbers of cardiovascu-
lar risk factors appears to be similar to the ﬁndings by Maas
et al.9 With increasing numbers of cardiovascular risk factors,
plasma nitrite appears to be lower. Because of the approxi-
mately 100-fold difference in concentrations of these 2 anions,
the differences in plasma concentrations between subjects
with differing risk factors cannot be explained by conversion of
one to the other. We have observed something similar in a
cohort with diabetes mellitus compared with healthy con-
trols.15 Following placebo supplementation, there was a trend
towards higher plasma nitrate in the subjects with diabetes
mellitus, though this did not reach signiﬁcance. Plasma nitrite
concentration was lower in subjects with diabetes mellitus
compared with controls: 232 (200, 265) nmol/L versus 285
(245, 348) nmol/L, P=0.019.
While the data in the Maas study are from fasting samples,
they do not solely reﬂect endogenous synthesis of nitrate.
Nitrate from the diet is still excreted by the kidneys up to
48 hours after ingestion.16 From these data it is not possible
to establish whether any associations are from diet or
endogenous synthesis alone.
The modest inverse association of plasma nitrate concen-
tration with estimated glomerular ﬁltration rate may partially
explain the observations of Maas and colleagues and go some
way to explaining an association with plasma nitrate concen-
tration and mortality found here.9 The ﬁnding that plasma
nitrate concentration is higher in those with renal impairment
is not, however, universally accepted.17,18 The effect of
declining renal function would be expected to have an impact
on plasma nitrate concentration, given that around 65% of
circulating nitrate is excreted by the kidneys within
48 hours.16 It is perhaps worth noting that the fractional
reabsorption of nitrate in the kidney is approximately 95%
with no evidence of a transport maximum.19
We have argued previously that a substance that is actively
secreted in saliva and avidly reabsorbed by the kidneys is
unlikely to be an unwanted toxin.4
The physiology of the nitrate–nitrite–nitric oxide cycle and
its role in health and disease remains poorly understood. It is
unlikely that we will ever be able to perform a large enough
study of sufﬁcient duration to elucidate the health effects of
long-term dietary nitrate supplementation. To better under-
stand the role of the nitrate–nitrite–nitric oxide system in both
health and pathological states over the long term, we need
prospectively designed studies where both plasma nitrate and
nitrite are measured along with 24-hour urinary nitrate
excretion. In the meantime a vegetable-rich diet, and by
extension a nitrate-rich diet, remains something that is likely
to be of beneﬁt.
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